| Literature DB >> 27096955 |
Shuangfeng Liu1,2, Fating Zhou1, Yang Shen1, Yingying Zhang1, Hongmei Yin3, Ye Zeng1, Jingxia Liu1, Zhiping Yan1, Xiaoheng Liu1.
Abstract
Laryngeal squamous cell carcinoma (LSCC) is one of the most commonly diagnosed malignancies with high occurrence of tumor metastasis, which usually exposes to fluid shear stress (FSS) in lymphatic channel and blood vessel. Epithelial-mesenchymal transition (EMT) is an important mechanism that induces metastasis and invasion of tumors. We hypothesized that FSS induced a progression of EMT in laryngeal squamous carcinoma. Accordingly, the Hep-2 cells were exposed to 1.4 dyn/cm2 FSS for different durations. Our results showed that most of cells changed their morphology from polygon to elongated spindle with well-organized F-actin and abundant lamellipodia/filopodia in protrusions. After removing the FSS, cells gradually recovered their flat polygon morphology. FSS induced Hep-2 cells to enhance their migration capacity in a time-dependent manner. In addition, FSS down-regulated E-cadherin, and simultaneously up-regulated N-cadherin, translocated β-catenin into the nucleus. These results confirmed that FSS induced the EMT in Hep-2 cells, and revealed a reversible mesenchymal-epithelial transition (MET) process when FSS was removed. We further examined the time-expressions of signaling cascades, and demonstrated that FSS induces the EMT and enhances cell migration depending on integrin-ILK/PI3K-AKT-Snail signaling events. The current study suggests that FSS, an important biophysical factor in tumor microenvironment, is a potential determinant of cell behavior and function regulation.Entities:
Keywords: cell migration; epithelial-mesenchymal transition (EMT); fluid shear stress (FSS); laryngeal squamous cell carcinomas (LSCC)
Mesh:
Substances:
Year: 2016 PMID: 27096955 PMCID: PMC5078059 DOI: 10.18632/oncotarget.8765
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Figure 1FSS induced the morphology and F-actin changes of Hep2 cells
A. The morphology of Hep-2 cells exposed to 1.4 dyn/cm2 FSS at different durations and observed under 100×(upper) and 200× (lower) magnification using the inverted microscope. The yellow and red marks in Figure 1A indicated the morphology of cloned cells presented polygon and spindle, respectively. The axial ratio of Hep-2 cells was statistically analyzed by Image J. The black and white scale bars in figures are 50 μm and 20 μm, respectively. B. Effects of FSS on distribution of F-actin arrays in Hep-2. Confocal immunofluorescence images showed localization of F-actin expose to FSS at 2h, 4h, 8h, in response to removing FSS at 4h and 8h, respectively. (green: F-actin; blue: nucleus, scale bar=20 μm). Designated regions indicated by red/yellow square frames and triangular marks in figures are enlarged to show the detailed fiber structure in the cell body and filopodia/lamellipodia at the edge of cell protrusions (scale bar=5 μm).
Figure 2FSS induced expression and distribution of E-cad and N-cad in Hep-2 cells
A. FSS induced expression of E-cad and N-cad. FSS inducing loss of E-cad led to an EMT process, and a reversible MET occur when FSS was removed. The expression levels of E-cad and N-cad were quantified by image analysis of the Western blot bands. Data are means ± SD from three independent experiments. *, means statistically significant difference with P<0.05. B. Exposing to FSS induced a changed location of E-cad and N-cad at the boundary of cells. C. The positive expression of E-cad and N-cad by flow cytometer at different duration of exposed and removed FSS.
Figure 3FSS induced expression level change and translocation of β-catenin in Hep-2 cells
A. FSS induced a changed expression of β-catenin in time-dependent manner. β-catenin level was quantified by image analysis of Western blot bands. *, means statistically significant difference with P<0.05. B. The presence or absence of FSS induced a translocation of β-catenin. FSS markedly induced an accumulation of β-catenin in nucleus (white marks), but translocated to cytomembrane (yellow marks) when FSS was removed.
Figure 4Fluid shear stress enhanced cell migration ability and changed cell-cell junctions
A. Exposed to FSS enhanced Hep-2 cell migration ability in a time-dependent manner. The 8h group (Hep-2 cells were exposed to FSS for 8h) showed the largest migrated distances and maximum migrated cell number at 24h, compared with control, 2h and 4h group. B. The TEM images showed that FSS decreased cell-cell junctions. The red marks and enlarged frames showed the junctions and gaps between two cells. The scale bars in TEM images of each group are 10μm and 2μm with gradual enhanced magnification (5000×and 20,000×). C. The effect of FSS on Occludin, Claudin-5 and ZO-1 expression. The expression levels were quantified and statistically analyzed by image analysis of Western blot bands. *, means statistically significant difference with P<0.05.
Figure 5FSS-induced EMT in Hep-2 cells depended on integrins signaling events
FSS regulated the expression change of A. integrins α and β subunits, B. ILK/PI3K/AKT signaling and, C. mesenchymal markers (Vimentin, Snail, Slug, and Twist). The expression levels were quantified and statistically analyzed by image analysis of Western blot bands. *, means statistically significant difference with P<0.05.
Figure 6FSS-induced EMT in Hep-2 cells depended on FAK signaling cascade
A. The F-actin changing by FSS in Hep-2 cells depended on the assembly of cytoskeletal proteins, Talin, Vinculin, Zyxin and α-actinin. B. FSS regulated the expression change of FAK. C. The Hep-2 cells with EMT enhance their migration ability depended on increased expression level of Rho-family GTPases (RhoA, Rac1 and Cdc42). The expression levels were quantified and statistically analyzed by image analysis of Western blot bands. *, means statistically significant difference with P<0.05.
Figure 7Sh-Snail1 inhibits the FSS-induced EMT in Hep-2 cells
A. The differences of cell morphology among the Hep-2 cells transfected with shRNA-mock or shRNA snail1 plasmids and control using inverted phase contrast microscope. The green fluorescence indicated that plasmids had been successfully transfected into Hep-2 cells using fluorescence microscope. B. Snail1 and N-cadherin expression levels following inhibition of Snail1 in Hep-2 cells analyzed by western blotting and RT-PCR. C. FSS induced expression of Snail, E-cad, N-cad, Twist and Vimentin in Sh-Snail Hep-2 cells. D. Wound scratch assay revealed that the cell migration distance in shRNA Snail1 was significantly shorter than that of control group after 24h.
Sample identification codes and preparation conditions
| Identification Codes | Fluid shear stress (dyn/cm2) | Stimulated duration of Shear stress | Static culture after cancelled shear stress |
|---|---|---|---|
| - | - | - | |
| 1.4 | 2h | - | |
| 1.4 | 4h | - | |
| 1.4 | 8h | - | |
| 1.4 | 8h | 4h | |
| 1.4 | 8h | 8h |
List of antibodies used in this study
| Category | Primary antibody name | Isotype | Blocking Conditions 1-hr room temperature | Primary Ab incubation | Manufacturer |
|---|---|---|---|---|---|
| E-cad/N-Cad | E-cadherin (H-108): sc-7870 | rabbit pAb mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | Santa Cruz, Inc |
| N-cadherin (H-4):sc-271386 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:100 dilution | ||
| Tight Junction components | Occludin (E-5): sc-133256 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | Santa Cruz, Inc |
| Claudin-5 (H-52):sc-28670 | rabbit pAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | ||
| ZO-1 (H-300):sc-10804 | rabbit pAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:100 dilution | ||
| Integrins | α2integrins (C-9):sc-74466 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | Santa Cruz, Inc |
| α5 integrins (A-11):sc-166665 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | ||
| αV (H-2):sc-376156 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:100 dilution | ||
| β1 (A-4):sc-374429 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | ||
| β3 (B-7):sc-46655 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | ||
| ILK/PI3K/( | ILK (65.1):sc-20019 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | Santa Cruz, Inc |
| PI3K C2β (16L9):sc-100407 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:100 dilution | ||
| AKT1 (B-1):sc-5298 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | ||
| rabbit pAb | 3% BSA in PBS | Overnight at 4°C, 1:200 dilution | |||
| Vimentin (V9): sc-6260 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | Santa Cruz, Inc | |
| Snail (H-130): sc-28199 | rabbit pAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:100 dilution | ||
| Slug (A-7): sc-166476 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | ||
| Twist (Twist2C1a): sc-81417 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:100 dilution | ||
| β-catenin | β-catenin (E-5): sc-7963 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:100 dilution | Santa Cruz, Inc |
| FA components | Talin (8D4):sc-59881 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | Santa Cruz, Inc |
| Vinculin (G-11):sc-55465 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | ||
| α-actinin (H-2):sc-17829 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | ||
| Zyxin (H-200):sc-15338 | rabbit pAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:100 dilution | ||
| FAK | FAK (A-17):sc-557 | rabbit pAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | Santa Cruz, Inc |
| Rho GTPases | Rac1 (C-11):sc-95 | rabbit pAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | Santa Cruz, Inc |
| RhoA (26C4):sc-418 | mouse mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:200 dilution | ||
| Cdc42 ab64533 | rabbit mAb | 5% nonfat dry milk in PBS | Overnight at 4°C, 1:100 dilution | Abcam®, Inc |
The detailed information of Snail shRNA Plasmids
| Clone Name | Symbol | Location | Length | Target Sequence |
|---|---|---|---|---|
| HSH017573-8-LVRH1GP (OS396160) | SNAI1 | 1465 | 19 | GAGTAATGGCTGTCACTTG |